BioNTech 2024年第四季度GAAP每股收益€1.08,或不具可比性,超出€0.38预期,销售额€11.9亿超出€10.9亿预期

财报速递2025-03-10
BioNTech(纳斯达克:BNTX)报告2024年第四季度每股收益€1.08,高于分析师普遍预期的€0.38,超出预期184.21%。与去年同期每股收益€1.88相比下降了42.55%。公司报告季度销售额€11.9亿,高于分析师共识的€10.9亿,超出预期9.04%。与去年同期的销售额€14.8亿相比下降了19.54%。

以上内容来自Benzinga Earnings专栏,原文如下:

BioNTech (NASDAQ:BNTX) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.38 by 184.21 percent. This is a 42.55 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $1.19 billion which beat the analyst consensus estimate of $1.09 billion by 9.04 percent. This is a 19.54 percent decrease over sales of $1.48 billion the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法